Amgen Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $33.22B | $6.70B | $7.99B |
| FY2022 | $37.35B | $3.66B | $7.63B |
| FY2023 | $63.17B | $6.23B | $10.94B |
| FY2024 | $56.55B | $5.88B | $11.97B |
| FY2025 | $50.01B | $8.66B | $9.13B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $33.22B | $6.70B | $7.99B |
| FY2022 | $37.35B | $3.66B | $7.63B |
| FY2023 | $63.17B | $6.23B | $10.94B |
| FY2024 | $56.55B | $5.88B | $11.97B |
| FY2025 | $50.01B | $8.66B | $9.13B |